We are live on
!
Find out more
Standard BioTools
LAB
LAB
80 hedge funds and large institutions have $389M invested in Standard BioTools in 2013 Q2 according to their latest regulatory filings, with 80 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+80
Holders Change %
–
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
80
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
California Public Employees Retirement System
Sacramento,
California
| $19K | +$19.3K | +1,100 | New |
|
77
BlackRock
New York
| $12K | +$12.1K | +689 | New |
|
78
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4K | +$4.05K | +231 | New |
|
79
Citigroup
New York
| $4K | +$4.09K | +233 | New |
|
|
RFC
80
Russell Frank Company
Seattle,
Washington
| $3K | +$2.72K | +155 | New |
|
LAB Hedge Fund Activity: Q2 2013 in Review
80 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2013, worth a combined $389M.
Buyers outnumbered sellers: 80 funds opened new LAB positions and 0 closed out — a net gain of 80 holders — while 0 added to existing stakes and 0 trimmed.
- 80 institutional investors held Standard BioTools (LAB) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $389M of Standard BioTools stock for Q2 2013.
- 80 funds opened new Standard BioTools positions in Q2 2013 and 0 closed out, a net change of +80 holders.
Based on aggregated 13F filings for Q2 2013.